Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
The Journal of Urology
|
March 1, 1991
In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer
L A Seraphim, S D Perrapato, H K Slocum, et al.
European Urology
|
January 1, 1987
Simple method for the management of hematuria caused by radiation or cytoxan
P M Livne, R P Huben, R M Wolf, et al.
Cancer
|
August 15, 1992
Prognostic factors in survival of bladder cancer
A Lopez-Beltran, G A Croghan, I Croghan, et al.
The Journal of Urology
|
June 1, 1994
Effect of perioperative chemoimmunotherapy with cyclophosphamide and autologous tumor vaccine in murine MBT-2 bladder cancer
T S Tzai, R P Huben, G Zaleskis, et al.
The Journal of Urology
|
October 1, 1984
Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa
T Zein, Z Wajsman, L S Englander, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I clinical trial of recombinant human tumor necrosis factor
P J Creaven, J E Plager, S Dupere, et al.
Journal of Medicine
|
January 1, 1989
Radio-protective effect of sodium meclofenamate. A prospective clinical trial
M Mahafzah, J Halpern, H R Nava, et al.
The Journal of Urology
|
June 1, 1984
Immediate postoperative feeding in urological surgery
E J Seidmon, K V Pizzimenti, F A Blumenstock, et al.
Urology
|
February 1, 1987
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma
G P Murphy, J M Greco, J L Chin, et al.
The Journal of Urology
|
December 1, 1989
Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder
J S Pan, H K Slocum, Y M Rustum, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
The Journal of Urology
|
March 1, 1991
In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer
L A Seraphim, S D Perrapato, H K Slocum, et al.
European Urology
|
January 1, 1987
Simple method for the management of hematuria caused by radiation or cytoxan
P M Livne, R P Huben, R M Wolf, et al.
Cancer
|
August 15, 1992
Prognostic factors in survival of bladder cancer
A Lopez-Beltran, G A Croghan, I Croghan, et al.
The Journal of Urology
|
June 1, 1994
Effect of perioperative chemoimmunotherapy with cyclophosphamide and autologous tumor vaccine in murine MBT-2 bladder cancer
T S Tzai, R P Huben, G Zaleskis, et al.
The Journal of Urology
|
October 1, 1984
Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa
T Zein, Z Wajsman, L S Englander, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I clinical trial of recombinant human tumor necrosis factor
P J Creaven, J E Plager, S Dupere, et al.
Journal of Medicine
|
January 1, 1989
Radio-protective effect of sodium meclofenamate. A prospective clinical trial
M Mahafzah, J Halpern, H R Nava, et al.
The Journal of Urology
|
June 1, 1984
Immediate postoperative feeding in urological surgery
E J Seidmon, K V Pizzimenti, F A Blumenstock, et al.
Urology
|
February 1, 1987
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma
G P Murphy, J M Greco, J L Chin, et al.
The Journal of Urology
|
December 1, 1989
Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder
J S Pan, H K Slocum, Y M Rustum, et al.
Page
of 9